Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, https://zakariaienk820435.snack-blog.com/36178670/tirzepatide-a-promising-new-treatment-for-obesity